BREATH TEST FOR DISEASE DETECTION
COVID-19
Breathonix BreFence™ Go COVID-19 Breath Test System has gained Singapore HSA Provisional Approval and Malaysia MOH Approval.
Other Fatal Diseases
Ongoing clinical trials to detect a wide range of diseases including early detection of Lung Cancer, Nasopharyngeal Cancer and Tuberculosis.
KEY HIGHLIGHTS
Slingshot 2019 MedTech Winner
Breathonix was the MedTech Sector Winner (out of 2400 startups) of Slingshot 2019 competition.
6+ Years of Breath Analysis Research
The technology is developed from 6+ years of breath analysis research.
Backed by Reputable Investors
Funded by Antler and Origgin VC.
COLLABORATION
To the ones who made it possible
JOIN OUR MISSION
Reimagine Diagnostics with Rapid Breath Test for Disease Detection
LATEST UPDATES
Breathonix is delighted to be chosen as an Urban Innovation Champion at Cities of the Future 2022. Join us on 2 March when we’ll be presenting our company’s story live alongside other Champions shaping tomorrow’s #smartcities ? https://bit.ly/3uLPL8w ?️2 Mar Organised in […]
Zühlke worked with Breathonix to set solid foundations for their solution architecture and identify opportunities through advanced technologies to scale their digital and innovation capabilities. Executive Summary Breathonix’s BreFence™ Go is the first COVID-19 system to receive provisional authorisation from […]
SINGAPORE, 16 July 2021 – Singapore-based firms Accredify and Breathonix today announced their collaboration to supply an on-site COVID-19 rapid-breath test system that issues digital verifiable COVID-19 test results compliant with countries’ international travel and domestic health requirements in less than […]